HIV treatment decreases cancer but still elevated risk
A large VA study found that overall cancer risk decreased with improved HIV viral suppression, but an increased residual risk remained (s ee hiv cancer dec still elevated AIM2018 in dropbox, or doi:10.7326/M16-2094 Details: --42,441 HIV-positive veterans were compared to 104,712 demographically matched uninfected veterans, from 1999-2015 -- 64% were 40-60 years old, 98% male, 40% non-Hispanic white/50% non-Hispanic black/9% Hispanic, 67% ever-smokers/27% never-smokers, 35% alcohol use disorder, 63% HCV negative/ 15% chronic HCV, 75% diabetes -- comparing the groups: similar distribution of age, sex, race/ethnicity, smoking status, alcohol use. Those with HIV had more chronic hepatitis C and a lower prevalence of diabetes -- HIV control: 22% unsuppressed (suppression defined as < 500 copies/mL), 27% early suppression (initial period up to 2 years of continuous suppressed observation time, but also includes those who were suppressed but then became unsuppressed...